Discontinued — last reported Q4 '25
Investing
Other Investing
Year-over-year, this metric declined by 100.0%, from $750.00K to $0.00. Over 2 years (FY 2023 to FY 2025), Other Investing shows a downward trend with a -100.0% CAGR.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryOther
SignalContext dependent
VolatilityStable
First reportedQ1 2013
Last reportedQ4 2025
How to read this metric
Generally neutral, but large fluctuations may indicate non-recurring events or specific financial adjustments that warrant further investigation.
Detailed definition
This metric aggregates miscellaneous cash inflows and outflows related to investing activities that do not fit into stan...
Peer comparison
Usually a small component of total investing cash flow; peers report similar miscellaneous items based on specific accounting treatments.
Metric ID:
other_investingHistorical Data
3 years
| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | $11.00M | $3.00M | $0.00 |
| YoY Change | — | -72.7% | -100.0% |
Range$0.00 – $11.00M
CAGR-100.0%
Avg YoY Growth-86.4%
Median YoY Growth-86.4%
Current Streak2+ years decline
Other Investing at Other Companies
Frequently Asked Questions
- What is Medline, Inc. 's other investing?
- Medline, Inc. (MDLN) reported other investing of $0.00 in Q4 2025.
- How has Medline, Inc. 's other investing changed year-over-year?
- Medline, Inc. 's other investing decreased by 100.0% year-over-year, from $750.00K to $0.00.
- What is the long-term trend for Medline, Inc. 's other investing?
- Over 2 years (2023 to 2025), Medline, Inc. 's other investing has grown at a -100.0% compound annual growth rate (CAGR), from $11.00M to $0.00.
- What does other investing mean?
- Miscellaneous cash flows related to investing that are not categorized elsewhere.